Bayer Advances Parkinson’s Cell And Gene Therapies Into First Human Studies

Recently-Acquired BlueRock and AskBio Move Ahead

 
• By Andrew McConaghie
  
Deep brain stimulation surgery for Parkinson's disease
BlueRock's therapy will involve the implanting of stem cells deep into the brains of Parkinson's disease patients, with the hope of restoring nerve cells and function. • Source: Alamy

More from Neurological

More from Therapy Areas